GB9105677D0 - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number: GB9105677D0
Authority: GB; United Kingdom
Prior art keywords: heterocyclic compounds; heterocyclic; compounds
Prior art date: 1991-03-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

GB919105677A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Imperial Chemical Industries Ltd

Original Assignee

Imperial Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-19

Filing date

1991-03-19

Publication date

1991-05-01

1991-03-19 Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd

1991-03-19 Priority to GB919105677A priority Critical patent/GB9105677D0/en

1991-05-01 Publication of GB9105677D0 publication Critical patent/GB9105677D0/en

1992-03-05 Priority to GB9204887A priority patent/GB2253848A/en

Status Pending legal-status Critical Current

Links

GB919105677A 1991-03-19 1991-03-19 Heterocyclic compounds Pending GB9105677D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GB919105677A GB9105677D0 (en)	1991-03-19	1991-03-19	Heterocyclic compounds
GB9204887A GB2253848A (en)	1991-03-19	1992-03-05	Heterocyclic compounds

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB919105677A GB9105677D0 (en)	1991-03-19	1991-03-19	Heterocyclic compounds

Publications (1)

Publication Number	Publication Date
GB9105677D0 true GB9105677D0 (en)	1991-05-01

Family

ID=10691744

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
GB919105677A Pending GB9105677D0 (en)	1991-03-19	1991-03-19	Heterocyclic compounds
GB9204887A Withdrawn GB2253848A (en)	1991-03-19	1992-03-05	Heterocyclic compounds

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
GB9204887A Withdrawn GB2253848A (en)	1991-03-19	1992-03-05	Heterocyclic compounds

Country Status (1)

Country	Link
GB (2)	GB9105677D0 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002032872A1 (en)	2000-10-20	2002-04-25	Eisai Co., Ltd.	Nitrogenous aromatic ring compounds
EP1347959A1 (en)	2000-12-27	2003-10-01	Bayer Aktiengesellschaft	Indole derivatives as ligands of thyroid receptors
WO2002070478A1 (en)	2001-03-06	2002-09-12	Astrazeneca Ab	Indolone derivatives having vascular-damaging activity
US7994159B2 (en)	2003-03-10	2011-08-09	Eisai R&D Management Co., Ltd.	c-Kit kinase inhibitor
CN100450998C (en)	2003-11-11	2009-01-14	卫材R&D管理有限公司	Process for the preparation of urea derivatives
ATE428421T1 (en)	2004-09-17	2009-05-15	Eisai R&D Man Co Ltd	MEDICAL COMPOSITION WITH IMPROVED STABILITY AND REDUCED GELING PROPERTIES
EP2281901B1 (en)	2005-08-02	2013-11-27	Eisai R&D Management Co., Ltd.	Anti-tumour pharmaceutical composition with angiogenesis inhibitors
AU2006309551B2 (en)	2005-11-07	2012-04-19	Eisai R & D Management Co., Ltd.	Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
ES2556173T3 (en)	2006-05-18	2016-01-13	Eisai R&D Management Co., Ltd.	Antitumor agent for thyroid cancer
CN101511793B (en)	2006-08-28	2011-08-03	卫材R&D管理有限公司	Antineoplastic agents against undifferentiated gastric cancer
CN101600694A (en)	2007-01-29	2009-12-09	卫材R&D管理有限公司	Composition for treatment of undifferentiated gastric cancer
EP2218712B1 (en)	2007-11-09	2015-07-01	Eisai R&D Management Co., Ltd.	Combination of anti-angiogenic substance and anti-tumor platinum complex
AU2011270165B2 (en)	2010-06-25	2015-12-24	Eisai R&D Management Co., Ltd.	Antitumor agent using compounds having kinase inhibitory effect in combination
KR101762999B1 (en)	2011-04-18	2017-07-28	에자이 알앤드디 매니지먼트 가부시키가이샤	Therapeutic agent for tumor
US9945862B2 (en)	2011-06-03	2018-04-17	Eisai R&D Management Co., Ltd.	Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
WO2014098176A1 (en)	2012-12-21	2014-06-26	エーザイ・アール・アンド・ディー・マネジメント株式会社	Amorphous form of quinoline derivative, and method for producing same
SG11201509278XA (en)	2013-05-14	2015-12-30	Eisai R&D Man Co Ltd	Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
PL3524595T3 (en)	2014-08-28	2022-10-31	Eisai R&D Management Co., Ltd.	High-purity quinoline derivative and method for manufacturing same
HUE064614T2 (en)	2015-02-25	2024-04-28	Eisai R&D Man Co Ltd	Process for suppressing the bitter taste of a quinoline derivative
WO2016140717A1 (en)	2015-03-04	2016-09-09	Merck Sharp & Dohme Corp.	Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
ES2886107T3 (en)	2015-06-16	2021-12-16	Prism Biolab Co Ltd	Antineoplastic
US12220398B2 (en)	2015-08-20	2025-02-11	Eisai R&D Management Co., Ltd.	Tumor therapeutic agent
KR102539920B1 (en)	2017-02-08	2023-06-05	에자이 알앤드디 매니지먼트 가부시키가이샤	Tumor-Treatment Pharmaceutical Composition
WO2018164214A1 (en) *	2017-03-08	2018-09-13	国立大学法人名古屋大学	Plant growth regulator
CA3061888A1 (en)	2017-05-16	2018-11-22	Eisai R&D Management Co., Ltd.	Treatment of hepatocellular carcinoma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE790391A (en) *	1971-10-20	1973-04-20	Squibb & Sons Inc	THIAZOLINYLINDOLES AND THIAZINYLINDOLES, THEIR PREPARATION AND THEIR THERAPEUTIC USES

1991
- 1991-03-19 GB GB919105677A patent/GB9105677D0/en active Pending
1992
- 1992-03-05 GB GB9204887A patent/GB2253848A/en not_active Withdrawn

Also Published As

Publication number	Publication date
GB9204887D0 (en)	1992-04-22
GB2253848A (en)	1992-09-23

Publication	Publication Date	Title
HU9202877D0 (en)	1992-11-30	Heterocyclic compounds
GB9125001D0 (en)	1992-01-22	Heterocyclic compounds
GB9204887D0 (en)	1992-04-22	Heterocyclic compounds
GB9205484D0 (en)	1992-04-29	Heterocyclic compounds
IL101251A0 (en)	1992-11-15	Heterocyclic compounds
GB9111131D0 (en)	1991-07-17	Heterocyclic compounds
OA09978A (en)	1996-03-29	Heterocyclic compounds
HU9302522D0 (en)	1993-12-28	Heterocyclic compounds
GB9123916D0 (en)	1992-01-02	Heterocyclic compounds
IL101252A0 (en)	1992-11-15	Heterocyclic compounds
GB9104769D0 (en)	1991-04-17	Heterocyclic compounds
IL101249A0 (en)	1992-11-15	Heterocyclic compounds
GB9117987D0 (en)	1991-10-09	Heterocyclic compounds
GB9204859D0 (en)	1992-04-22	Heterocyclic compounds
AP9200435A0 (en)	1992-10-31	Heterocyclic compounds
GB9215645D0 (en)	1992-09-09	Heterocyclic compounds
GB9104870D0 (en)	1991-04-17	Heterocyclic compounds
GB9106605D0 (en)	1991-05-15	Heterocyclic compounds
GB9108217D0 (en)	1991-06-05	Heterocyclic compounds
GB9116314D0 (en)	1991-09-11	Heterocyclic compounds
GB9116575D0 (en)	1991-09-18	Heterocyclic compounds
GB9101379D0 (en)	1991-03-06	Heterocyclic compounds
GB9106714D0 (en)	1991-05-15	Heterocyclic compounds
GB9104770D0 (en)	1991-04-17	Heterocyclic compounds
GB9121149D0 (en)	1991-11-13	Heterocyclic compounds